世界の糖尿病黄斑浮腫治療薬市場規模・現状・予測2021-2027

【英語タイトル】Global Diabetic Macular Edema Drug Market Size, Status and Forecast 2021-2027

QYResearchが出版した調査資料(QY21APR1833)・商品コード:QY21APR1833
・発行会社(調査会社):QYResearch
・発行日:2021年4月(※2024年版があります。お問い合わせください)
・ページ数:99
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医薬品、ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査資料では、糖尿病黄斑浮腫治療薬の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(硝子体内注射、硝子体内インプラント)、用途別市場規模(抗VEGF、コルチコステロイド、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・糖尿病黄斑浮腫治療薬の市場動向
・企業の競争状況、市場シェア
・糖尿病黄斑浮腫治療薬の種類別市場規模(硝子体内注射、硝子体内インプラント)
・糖尿病黄斑浮腫治療薬の用途別市場規模(抗VEGF、コルチコステロイド、その他)
・糖尿病黄斑浮腫治療薬の北米市場規模2016-2027(アメリカ、カナダ)
・糖尿病黄斑浮腫治療薬の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・糖尿病黄斑浮腫治療薬のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・糖尿病黄斑浮腫治療薬の中南米市場規模2016-2027(メキシコ、ブラジル)
・糖尿病黄斑浮腫治療薬の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Novartis、Bayer、Allergan、Hoffman-La Roche、Alimera、Valeant)
・結論
【レポートの概要】

Market Analysis and Insights: Global Diabetic Macular Edema Drug Market
The global Diabetic Macular Edema Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Diabetic Macular Edema Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Diabetic Macular Edema Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Diabetic Macular Edema Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Diabetic Macular Edema Drug market.

Global Diabetic Macular Edema Drug Scope and Market Size
Diabetic Macular Edema Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Diabetic Macular Edema Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Intravitreal Injections
Intravitreal Implants

Segment by Application
Anti-VEGF
Corticosteroids
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novartis
Bayer
Allergan
Hoffman-La Roche
Alimera
Valeant

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetic Macular Edema Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Intravitreal Injections
1.2.3 Intravitreal Implants
1.3 Market by Application
1.3.1 Global Diabetic Macular Edema Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Anti-VEGF
1.3.3 Corticosteroids
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Diabetic Macular Edema Drug Market Perspective (2016-2027)
2.2 Diabetic Macular Edema Drug Growth Trends by Regions
2.2.1 Diabetic Macular Edema Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Diabetic Macular Edema Drug Historic Market Share by Regions (2016-2021)
2.2.3 Diabetic Macular Edema Drug Forecasted Market Size by Regions (2022-2027)
2.3 Diabetic Macular Edema Drug Industry Dynamic
2.3.1 Diabetic Macular Edema Drug Market Trends
2.3.2 Diabetic Macular Edema Drug Market Drivers
2.3.3 Diabetic Macular Edema Drug Market Challenges
2.3.4 Diabetic Macular Edema Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Diabetic Macular Edema Drug Players by Revenue
3.1.1 Global Top Diabetic Macular Edema Drug Players by Revenue (2016-2021)
3.1.2 Global Diabetic Macular Edema Drug Revenue Market Share by Players (2016-2021)
3.2 Global Diabetic Macular Edema Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Diabetic Macular Edema Drug Revenue
3.4 Global Diabetic Macular Edema Drug Market Concentration Ratio
3.4.1 Global Diabetic Macular Edema Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetic Macular Edema Drug Revenue in 2020
3.5 Diabetic Macular Edema Drug Key Players Head office and Area Served
3.6 Key Players Diabetic Macular Edema Drug Product Solution and Service
3.7 Date of Enter into Diabetic Macular Edema Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Diabetic Macular Edema Drug Breakdown Data by Type
4.1 Global Diabetic Macular Edema Drug Historic Market Size by Type (2016-2021)
4.2 Global Diabetic Macular Edema Drug Forecasted Market Size by Type (2022-2027)

5 Diabetic Macular Edema Drug Breakdown Data by Application
5.1 Global Diabetic Macular Edema Drug Historic Market Size by Application (2016-2021)
5.2 Global Diabetic Macular Edema Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Diabetic Macular Edema Drug Market Size (2016-2027)
6.2 North America Diabetic Macular Edema Drug Market Size by Type
6.2.1 North America Diabetic Macular Edema Drug Market Size by Type (2016-2021)
6.2.2 North America Diabetic Macular Edema Drug Market Size by Type (2022-2027)
6.2.3 North America Diabetic Macular Edema Drug Market Size by Type (2016-2027)
6.3 North America Diabetic Macular Edema Drug Market Size by Application
6.3.1 North America Diabetic Macular Edema Drug Market Size by Application (2016-2021)
6.3.2 North America Diabetic Macular Edema Drug Market Size by Application (2022-2027)
6.3.3 North America Diabetic Macular Edema Drug Market Size by Application (2016-2027)
6.4 North America Diabetic Macular Edema Drug Market Size by Country
6.4.1 North America Diabetic Macular Edema Drug Market Size by Country (2016-2021)
6.4.2 North America Diabetic Macular Edema Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Diabetic Macular Edema Drug Market Size (2016-2027)
7.2 Europe Diabetic Macular Edema Drug Market Size by Type
7.2.1 Europe Diabetic Macular Edema Drug Market Size by Type (2016-2021)
7.2.2 Europe Diabetic Macular Edema Drug Market Size by Type (2022-2027)
7.2.3 Europe Diabetic Macular Edema Drug Market Size by Type (2016-2027)
7.3 Europe Diabetic Macular Edema Drug Market Size by Application
7.3.1 Europe Diabetic Macular Edema Drug Market Size by Application (2016-2021)
7.3.2 Europe Diabetic Macular Edema Drug Market Size by Application (2022-2027)
7.3.3 Europe Diabetic Macular Edema Drug Market Size by Application (2016-2027)
7.4 Europe Diabetic Macular Edema Drug Market Size by Country
7.4.1 Europe Diabetic Macular Edema Drug Market Size by Country (2016-2021)
7.4.2 Europe Diabetic Macular Edema Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Diabetic Macular Edema Drug Market Size (2016-2027)
8.2 Asia-Pacific Diabetic Macular Edema Drug Market Size by Type
8.2.1 Asia-Pacific Diabetic Macular Edema Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Diabetic Macular Edema Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Diabetic Macular Edema Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Diabetic Macular Edema Drug Market Size by Application
8.3.1 Asia-Pacific Diabetic Macular Edema Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Diabetic Macular Edema Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Diabetic Macular Edema Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Diabetic Macular Edema Drug Market Size by Region
8.4.1 Asia-Pacific Diabetic Macular Edema Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Diabetic Macular Edema Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Diabetic Macular Edema Drug Market Size (2016-2027)
9.2 Latin America Diabetic Macular Edema Drug Market Size by Type
9.2.1 Latin America Diabetic Macular Edema Drug Market Size by Type (2016-2021)
9.2.2 Latin America Diabetic Macular Edema Drug Market Size by Type (2022-2027)
9.2.3 Latin America Diabetic Macular Edema Drug Market Size by Type (2016-2027)
9.3 Latin America Diabetic Macular Edema Drug Market Size by Application
9.3.1 Latin America Diabetic Macular Edema Drug Market Size by Application (2016-2021)
9.3.2 Latin America Diabetic Macular Edema Drug Market Size by Application (2022-2027)
9.3.3 Latin America Diabetic Macular Edema Drug Market Size by Application (2016-2027)
9.4 Latin America Diabetic Macular Edema Drug Market Size by Country
9.4.1 Latin America Diabetic Macular Edema Drug Market Size by Country (2016-2021)
9.4.2 Latin America Diabetic Macular Edema Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Diabetic Macular Edema Drug Market Size (2016-2027)
10.2 Middle East & Africa Diabetic Macular Edema Drug Market Size by Type
10.2.1 Middle East & Africa Diabetic Macular Edema Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Diabetic Macular Edema Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Diabetic Macular Edema Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Diabetic Macular Edema Drug Market Size by Application
10.3.1 Middle East & Africa Diabetic Macular Edema Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Diabetic Macular Edema Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Diabetic Macular Edema Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Diabetic Macular Edema Drug Market Size by Country
10.4.1 Middle East & Africa Diabetic Macular Edema Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Diabetic Macular Edema Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Diabetic Macular Edema Drug Introduction
11.1.4 Novartis Revenue in Diabetic Macular Edema Drug Business (2016-2021)
11.1.5 Novartis Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Diabetic Macular Edema Drug Introduction
11.2.4 Bayer Revenue in Diabetic Macular Edema Drug Business (2016-2021)
11.2.5 Bayer Recent Development
11.3 Allergan
11.3.1 Allergan Company Details
11.3.2 Allergan Business Overview
11.3.3 Allergan Diabetic Macular Edema Drug Introduction
11.3.4 Allergan Revenue in Diabetic Macular Edema Drug Business (2016-2021)
11.3.5 Allergan Recent Development
11.4 Hoffman-La Roche
11.4.1 Hoffman-La Roche Company Details
11.4.2 Hoffman-La Roche Business Overview
11.4.3 Hoffman-La Roche Diabetic Macular Edema Drug Introduction
11.4.4 Hoffman-La Roche Revenue in Diabetic Macular Edema Drug Business (2016-2021)
11.4.5 Hoffman-La Roche Recent Development
11.5 Alimera
11.5.1 Alimera Company Details
11.5.2 Alimera Business Overview
11.5.3 Alimera Diabetic Macular Edema Drug Introduction
11.5.4 Alimera Revenue in Diabetic Macular Edema Drug Business (2016-2021)
11.5.5 Alimera Recent Development
11.6 Valeant
11.6.1 Valeant Company Details
11.6.2 Valeant Business Overview
11.6.3 Valeant Diabetic Macular Edema Drug Introduction
11.6.4 Valeant Revenue in Diabetic Macular Edema Drug Business (2016-2021)
11.6.5 Valeant Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Diabetic Macular Edema Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Intravitreal Injections
Table 3. Key Players of Intravitreal Implants
Table 4. Global Diabetic Macular Edema Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Diabetic Macular Edema Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Diabetic Macular Edema Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Diabetic Macular Edema Drug Market Share by Regions (2016-2021)
Table 8. Global Diabetic Macular Edema Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Diabetic Macular Edema Drug Market Share by Regions (2022-2027)
Table 10. Diabetic Macular Edema Drug Market Trends
Table 11. Diabetic Macular Edema Drug Market Drivers
Table 12. Diabetic Macular Edema Drug Market Challenges
Table 13. Diabetic Macular Edema Drug Market Restraints
Table 14. Global Diabetic Macular Edema Drug Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Diabetic Macular Edema Drug Market Share by Players (2016-2021)
Table 16. Global Top Diabetic Macular Edema Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Macular Edema Drug as of 2020)
Table 17. Ranking of Global Top Diabetic Macular Edema Drug Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Diabetic Macular Edema Drug Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Diabetic Macular Edema Drug Product Solution and Service
Table 21. Date of Enter into Diabetic Macular Edema Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Diabetic Macular Edema Drug Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Diabetic Macular Edema Drug Revenue Market Share by Type (2016-2021)
Table 25. Global Diabetic Macular Edema Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Diabetic Macular Edema Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Diabetic Macular Edema Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Diabetic Macular Edema Drug Revenue Market Share by Application (2016-2021)
Table 29. Global Diabetic Macular Edema Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Diabetic Macular Edema Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Diabetic Macular Edema Drug Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Diabetic Macular Edema Drug Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Diabetic Macular Edema Drug Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Diabetic Macular Edema Drug Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Diabetic Macular Edema Drug Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Diabetic Macular Edema Drug Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Diabetic Macular Edema Drug Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Diabetic Macular Edema Drug Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Diabetic Macular Edema Drug Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Diabetic Macular Edema Drug Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Diabetic Macular Edema Drug Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Diabetic Macular Edema Drug Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Diabetic Macular Edema Drug Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Diabetic Macular Edema Drug Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Diabetic Macular Edema Drug Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Diabetic Macular Edema Drug Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Diabetic Macular Edema Drug Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Diabetic Macular Edema Drug Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Diabetic Macular Edema Drug Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Diabetic Macular Edema Drug Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Diabetic Macular Edema Drug Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Diabetic Macular Edema Drug Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Diabetic Macular Edema Drug Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Diabetic Macular Edema Drug Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Diabetic Macular Edema Drug Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Diabetic Macular Edema Drug Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Diabetic Macular Edema Drug Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Diabetic Macular Edema Drug Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Diabetic Macular Edema Drug Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Diabetic Macular Edema Drug Market Size by Country (2022-2027) & (US$ Million)
Table 61. Novartis Company Details
Table 62. Novartis Business Overview
Table 63. Novartis Diabetic Macular Edema Drug Product
Table 64. Novartis Revenue in Diabetic Macular Edema Drug Business (2016-2021) & (US$ Million)
Table 65. Novartis Recent Development
Table 66. Bayer Company Details
Table 67. Bayer Business Overview
Table 68. Bayer Diabetic Macular Edema Drug Product
Table 69. Bayer Revenue in Diabetic Macular Edema Drug Business (2016-2021) & (US$ Million)
Table 70. Bayer Recent Development
Table 71. Allergan Company Details
Table 72. Allergan Business Overview
Table 73. Allergan Diabetic Macular Edema Drug Product
Table 74. Allergan Revenue in Diabetic Macular Edema Drug Business (2016-2021) & (US$ Million)
Table 75. Allergan Recent Development
Table 76. Hoffman-La Roche Company Details
Table 77. Hoffman-La Roche Business Overview
Table 78. Hoffman-La Roche Diabetic Macular Edema Drug Product
Table 79. Hoffman-La Roche Revenue in Diabetic Macular Edema Drug Business (2016-2021) & (US$ Million)
Table 80. Hoffman-La Roche Recent Development
Table 81. Alimera Company Details
Table 82. Alimera Business Overview
Table 83. Alimera Diabetic Macular Edema Drug Product
Table 84. Alimera Revenue in Diabetic Macular Edema Drug Business (2016-2021) & (US$ Million)
Table 85. Alimera Recent Development
Table 86. Valeant Company Details
Table 87. Valeant Business Overview
Table 88. Valeant Diabetic Macular Edema Drug Product
Table 89. Valeant Revenue in Diabetic Macular Edema Drug Business (2016-2021) & (US$ Million)
Table 90. Valeant Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diabetic Macular Edema Drug Market Share by Type: 2020 VS 2027
Figure 2. Intravitreal Injections Features
Figure 3. Intravitreal Implants Features
Figure 4. Global Diabetic Macular Edema Drug Market Share by Application: 2020 VS 2027
Figure 5. Anti-VEGF Case Studies
Figure 6. Corticosteroids Case Studies
Figure 7. Others Case Studies
Figure 8. Diabetic Macular Edema Drug Report Years Considered
Figure 9. Global Diabetic Macular Edema Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Diabetic Macular Edema Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Diabetic Macular Edema Drug Market Share by Regions: 2020 VS 2027
Figure 12. Global Diabetic Macular Edema Drug Market Share by Regions (2022-2027)
Figure 13. Global Diabetic Macular Edema Drug Market Share by Players in 2020
Figure 14. Global Top Diabetic Macular Edema Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Macular Edema Drug as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Diabetic Macular Edema Drug Revenue in 2020
Figure 16. Global Diabetic Macular Edema Drug Revenue Market Share by Type (2016-2021)
Figure 17. Global Diabetic Macular Edema Drug Revenue Market Share by Type (2022-2027)
Figure 18. North America Diabetic Macular Edema Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Diabetic Macular Edema Drug Market Share by Type (2016-2027)
Figure 20. North America Diabetic Macular Edema Drug Market Share by Application (2016-2027)
Figure 21. North America Diabetic Macular Edema Drug Market Share by Country (2016-2027)
Figure 22. United States Diabetic Macular Edema Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Diabetic Macular Edema Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Diabetic Macular Edema Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Diabetic Macular Edema Drug Market Share by Type (2016-2027)
Figure 26. Europe Diabetic Macular Edema Drug Market Share by Application (2016-2027)
Figure 27. Europe Diabetic Macular Edema Drug Market Share by Country (2016-2027)
Figure 28. Germany Diabetic Macular Edema Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Diabetic Macular Edema Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Diabetic Macular Edema Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Diabetic Macular Edema Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Diabetic Macular Edema Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Diabetic Macular Edema Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Diabetic Macular Edema Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Diabetic Macular Edema Drug Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Diabetic Macular Edema Drug Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Diabetic Macular Edema Drug Market Share by Region (2016-2027)
Figure 38. China Diabetic Macular Edema Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Diabetic Macular Edema Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Diabetic Macular Edema Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Diabetic Macular Edema Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Diabetic Macular Edema Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Diabetic Macular Edema Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Diabetic Macular Edema Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Diabetic Macular Edema Drug Market Share by Type (2016-2027)
Figure 46. Latin America Diabetic Macular Edema Drug Market Share by Application (2016-2027)
Figure 47. Latin America Diabetic Macular Edema Drug Market Share by Country (2016-2027)
Figure 48. Mexico Diabetic Macular Edema Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Diabetic Macular Edema Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Diabetic Macular Edema Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Diabetic Macular Edema Drug Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Diabetic Macular Edema Drug Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Diabetic Macular Edema Drug Market Share by Country (2016-2027)
Figure 54. Turkey Diabetic Macular Edema Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Diabetic Macular Edema Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Diabetic Macular Edema Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Novartis Revenue Growth Rate in Diabetic Macular Edema Drug Business (2016-2021)
Figure 58. Bayer Revenue Growth Rate in Diabetic Macular Edema Drug Business (2016-2021)
Figure 59. Allergan Revenue Growth Rate in Diabetic Macular Edema Drug Business (2016-2021)
Figure 60. Hoffman-La Roche Revenue Growth Rate in Diabetic Macular Edema Drug Business (2016-2021)
Figure 61. Alimera Revenue Growth Rate in Diabetic Macular Edema Drug Business (2016-2021)
Figure 62. Valeant Revenue Growth Rate in Diabetic Macular Edema Drug Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed


【掲載企業】

Novartis、Bayer、Allergan、Hoffman-La Roche、Alimera、Valeant

★調査レポート[世界の糖尿病黄斑浮腫治療薬市場規模・現状・予測2021-2027] (コード:QY21APR1833)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の糖尿病黄斑浮腫治療薬市場規模・現状・予測2021-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆